All case studies
PharmaceuticalsCloudAutomationQuality Assurance

Global Pharmaceutical Company

Daily medicine reporting, made automatic.

Delivering an end-to-end automated SaaS platform for daily medicine stock and commercial-operation reporting in Romania, built on AWS Amplify in less than two months.

Project context

Delivery window

Less than two months

Industry

Pharmaceuticals

Platforms

Responsive web application · Managed SaaS platform

The solution supports reporting workflows for medicine stocks and commercial operations submitted through Romania’s electronic reporting system, SER.

Its functional scope was designed around the reporting obligations described by Romanian Ministry of Health Order 1345/2016 for authorised medicine manufacturers, importers, wholesale distributors, and pharmacies.

The end client is one of the largest pharmaceutical companies operating in Romania and internationally. Its identity is withheld under client confidentiality.

The challenge

Daily regulated reporting involved strict data, identity, timing, and traceability requirements. The client needed a secure way to prepare and submit stock and invoice information, support both manual and automated reporting, track every attempt, adapt as requirements changed, and avoid taking ownership of complex infrastructure.

How we moved

  1. 01Translated the Order 1345/2016 reporting workflow into product requirements, validation rules, and traceable acceptance criteria
  2. 02Designed a serverless multi-user SaaS architecture on AWS Amplify with managed scaling and security controls
  3. 03Implemented secure authentication, MFA, user administration, and certificate-based interaction with SER
  4. 04Built manual and automated daily reporting, medicine-catalogue management, dashboards, and per-user reporting history
  5. 05Automated build, deployment, environment delivery, monitoring, and end-to-end functional testing

Delivery methodology

Shared logic. Platform judgement.

01

Regulation into workflow

Reporting duties, timing constraints, data fields, identity requirements, and exception paths were converted into explicit application behaviour and acceptance criteria.

02

Serverless by design

AWS Amplify and managed AWS services provided a modular foundation that could scale with demand without transferring server administration to the client.

03

Automation throughout

The reporting workflow, delivery pipeline, environment updates, monitoring, and operational alerts were designed to minimise repetitive manual intervention.

04

Quality as a release condition

End-to-end tests exercised complete user and reporting journeys, while automated delivery made the same checks repeatable for every release.

The solution

PharmaTrack is a secure SaaS reporting platform that supports daily stock and invoice reporting to SER and the relevant Romanian health authorities. It combines MFA-protected access, user management, reporting dashboards, manual and automated submissions, per-user activity history, medicine-catalogue maintenance, encrypted reporting, qualified-certificate authentication, monitoring, and managed cloud operations in one service.

Business outcomes

<2 mo
complete SaaS solution delivered

Measured from implementation start through delivery of the production-ready scope described in this case study.

Daily
regulated reporting cadence supported

The product supports the daily stock and commercial-operation reporting workflow for which it was designed.

E2E
automated delivery and testing

Build, deployment, and complete functional journeys were automated and exercised through end-to-end tests.

SaaS
managed operating model

MTD provided the web application and its cloud infrastructure as a managed service rather than transferring server operations to the client.

From requirement to delivered state

Reporting workflow

Starting point

Daily submissions required a dependable process across stock, invoice, product, and reporting information.

Delivered state

One workflow for manual or automated submission, status visibility, and reporting history.

Identity and access

Starting point

Sensitive reporting actions required controlled user access and trusted interaction with SER.

Delivered state

MFA, role-aware user management, secure sessions, and qualified-certificate authentication for SER interaction.

Cloud operations

Starting point

The client did not want to administer application servers and supporting infrastructure.

Delivered state

A managed, serverless AWS foundation with automated scaling, updates, monitoring, and alerting.

Release assurance

Starting point

Frequent regulatory or functional changes needed a repeatable path to production.

Delivered state

Automated delivery backed by end-to-end tests covering complete product journeys.

Capabilities

Technology

AWS AmplifyServerless AWS servicesMulti-factor authenticationQualified digital certificatesAutomated CI/CDEnd-to-end test automationMonitoring and real-time alerts

Evidence & disclosure

The pharmaceutical company’s identity is withheld under client confidentiality. The sector, reporting context, architecture, technology, delivery method, and product scope are published without identifying the organisation.

Published 24 August 2026

Next case study

A mortgage journey built around momentum.

Bring us your business challenge